Insider trading

Period: 120 months Stock: AGIO + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

279 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

279 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

279 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

279 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
279 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
279 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

279 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
13 Mar 2023
Sold, plan not stated 2×
$449.82K 20,000 at 22.49
14.5%
3 Mar 2023
Washburn Theodore James Jr. Principal Accounting Officer
Sold, plan not stated
$12.24K 504 at 24.29
15.5%
27 Feb 2023
Sold, plan not stated
$507.40K 20,000 at 25.37
14.5%
16 Feb 2023
Washburn Theodore James Jr. Principal Accounting Officer
Sold, plan not stated
$6.34K 233 at 27.21
8.0%
14 Feb 2023
Washburn Theodore James Jr. Principal Accounting Officer
Sold, plan not stated
$14.41K 504 at 28.59
14.8%
13 Feb 2023
Sold, plan not stated
$572.40K 20,000 at 28.62
14.5%
30 Jan 2023
Sold, plan not stated 2×
$586.58K 20,000 at 29.33
14.5%
17 Jan 2023
Sold, plan not stated 2×
$577.09K 20,000 at 28.85
14.5%
25 Feb 2022
Washburn Theodore James Jr. Principal Accounting Officer
Sold, plan not stated
$3.24K 108 at 30.00
4.1%
16 Feb 2022
Washburn Theodore James Jr. Principal Accounting Officer
Sold, plan not stated
$7.18K 233 at 30.81
8.4%
14 Feb 2022
Washburn Theodore James Jr. Principal Accounting Officer
Sold, plan not stated
$15.75K 504 at 31.25
15.3%
21 Jun 2021
Alenson Carman Principal Accounting Officer
Sold, plan not stated
$109.48K 1,777 at 61.61
100%
Sold half or more
18 Jun 2021
Bowden Christopher Chief Medical Officer
Sold, plan not stated
$2.91M 48,493 at 60.11
75.8%
Sold half or more
17 Jun 2021
Bowden Christopher Chief Medical Officer
Sold, plan not stated
$150.17K 2,502 at 60.02
13.9%
10 Jun 2021
Bowden Christopher Chief Medical Officer
Sold, plan not stated
$1.25M 20,853 at 60.06
57.4%
Sold half or more
9 Jun 2021
Bowden Christopher Chief Medical Officer
Sold, plan not stated
$430.12K 7,149 at 60.16
31.6%
8 Jun 2021
Bowden Christopher Chief Medical Officer
Sold, plan not stated
$400.94K 6,675 at 60.07
30.1%
7 Jun 2021
Bowden Christopher Chief Medical Officer
Sold, plan not stated
$256.23K 4,268 at 60.04
21.6%
14 May 2021
Miles Darrin Chief Commercial Officer
Sold, plan not stated
$191.83K 3,462 at 55.41
32.4%
20 Apr 2021
Bowden Christopher Chief Medical Officer
Sold, plan not stated
$793.58K 14,401 at 55.11
48.2%
19 Apr 2021
Bowden Christopher Chief Medical Officer
Sold, plan not stated
$177.05K 3,210 at 55.16
17.2%
16 Apr 2021
Alenson Carman Principal Accounting Officer
Sold, plan not stated
$62.49K 1,118 at 55.89
100%
Sold half or more
15 Apr 2021
Alenson Carman Principal Accounting Officer
Sold, plan not stated
$53.51K 991 at 54.00
47.0%
5 Mar 2021
Miles Darrin Chief Commercial Officer
Sold, plan not stated
$24.29K 500 at 48.58
4.5%
1 Mar 2021
Miles Darrin Chief Commercial Officer
Sold, plan not stated
$105.58K 2,200 at 47.99
16.5%
2 Sep 2020
Alenson Carman Principal Accounting Officer
Sold, plan not stated
$9.98K 250 at 39.93
57.6%
Sold half or more
20 May 2020
Bowden Christopher Chief Medical Officer
Sold, plan not stated
$179.20K 3,583 at 50.01
30.1%
2 Mar 2020
Alenson Carman Principal Accounting Officer
Sold, plan not stated
$16.32K 345 at 47.30
65.2%
Sold half or more
26 Feb 2020
Alenson Carman Principal Accounting Officer
Sold, plan not stated
$22.24K 472 at 47.12
72.0%
Sold half or more
20 Feb 2020
Alenson Carman Principal Accounting Officer
Sold, plan not stated
$129.53K 2,427 at 53.37
93.0%
Sold half or more
13 Feb 2020
Bowden Christopher Chief Medical Officer
Sold, plan not stated
$356.11K 7,100 at 50.16
81.1%
Sold half or more
11 Feb 2020
Bowden Christopher Chief Medical Officer
Sold, plan not stated
$31.06K 621 at 50.02
27.3%
4 Feb 2020
Bowden Christopher Chief Medical Officer
Sold, plan not stated 2×
$2.49M 49,638 at 50.08
96.8%
Sold half or more
26 Dec 2019
Alenson Carman Principal Accounting Officer
Sold, plan not stated
$147.77K 2,950 at 50.09
94.1%
Sold half or more
13 Nov 2019
FOUSE JACQUALYN A Chief Executive Officer
Bought
$1.25M 40,322 at 31.00
×29
First buy on file
13 Nov 2019
Bought
$249.98K 8,064 at 31.00
9.0%
First buy on file
12 Nov 2019
CELGENE CORP /DE/ 10% owner
Bought
$12.50M 403,225 at 31.00
29.3%
First buy on file
5 Apr 2019
Biller Scott Chief Scientific Officer
Sold, plan not stated 2×
$203.14K 3,000 at 67.71
10.2%
1 Apr 2019
Bowden Christopher Chief Medical Officer
Sold, plan not stated 4×
$665.75K 10,000 at 66.57
58.0%
Sold half or more
15 Mar 2019
Bowden Christopher Chief Medical Officer
Sold, plan not stated 2×
$641.62K 10,000 at 64.16
58.0%
Sold half or more
5 Mar 2019
Biller Scott Chief Scientific Officer
Sold, plan not stated 3×
$203.03K 3,000 at 67.68
10.2%
4 Mar 2019
Hoerter Steven L. Chief Commercial Officer
Sold, plan not stated
$340.00K 5,000 at 68.00
31.4%
1 Mar 2019
Hoerter Steven L. Chief Commercial Officer
Sold, plan not stated
$330.05K 5,000 at 66.01
31.4%
27 Feb 2019
Biller Scott Chief Scientific Officer
Sold, plan not stated
$585.00K 9,000 at 65.00
25.3%
5 Nov 2018
Biller Scott Chief Scientific Officer
Sold, plan not stated 3×
$209.07K 3,000 at 69.69
5.6%
5 Oct 2018
Biller Scott Chief Scientific Officer
Sold, plan not stated 4×
$209.38K 3,000 at 69.79
5.6%
28 Sep 2018
Alenson Carman Principal Accounting Officer
Sold, plan not stated
$11.62K 152 at 76.45
100%
Sold half or more
12 Sep 2018
MARAGANORE JOHN Director
Sold, plan not stated
$1.02M 14,162 at 71.74
39.1%
11 Sep 2018
MARAGANORE JOHN Director
Sold, plan not stated 2×
$986.13K 13,555 at 72.75
27.2%
5 Sep 2018
Biller Scott Chief Scientific Officer
Sold, plan not stated 3×
$249.22K 3,000 at 83.07
5.0%
Showing 101–150 of 279. ← Newer Page 3 of 6 Older →